Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646 · cited 2×
“The methylation status was also con®rmed by restriction cut analysis of the MSP products with BstUI, as previously described (Herman et al., 1996a).”
MethodInfluentialSelf-citationCancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60702-2 · Cited by 1,928 · cited 7×
“Methylation is the main epigenetic modi®cation in humans (Baylin et al., 1998) and changes in patterns of this process play an important role in tumorigenesis.”
BackgroundInfluentialIncidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887 · cited 3×
“…to lack LKB1 mutations. bTumors with LOH at LKB locus. cTumors characteristic of Peutz-Jeghers syndrome Oncogene cing of the hMLH1 by promoter hypermethylation is a frequent event in sporadic colon and endometrial carcinomas with MSI (Kane et al., 1997; Herman et al., 1998; Esteller et al., 1998b).”
BackgroundInfluentialSelf-citationA serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,656 · cited 4×
“LKB1 encodes a widely expressed serine/ threonine kinase highly conserved in mouse and Xenopus (Hemminki et al., 1998).”
BackgroundInfluentialSelf-citationPeutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinase
Jenne, D. E., Reomann, H., Nezu, J.-I., Friedel, W., Loff., S., Jeschke, R., Müller, O., Back, W., & Zimmer, M. (1998) · Nature Genetics · doi:10.1038/ng0198-38 · Cited by 1,205 · cited 2×
“3 cause Peutz-Jeghers syndrome (PJS) (Hemminki et al., 1998; Jenne et al., 1998).”
BackgroundIncreased Risk of Cancer in the Peutz–Jeghers Syndrome
Giardiello, F. M., Welsh, S. B., Hamilton, S. R., Offerhaus, G. J. A., Gittelsohn, A. M., Booker, S. V., Krush, A. J., Yardley, J. H., & Luk, G. D. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706113162404 · Cited by 848 · cited 4×
“We then studied a third set of sporadic tumors composed exclusively of the speci®c histologic subtypes typical of PJS (Tomlinson and Houlston, 1997; Giardiello et al., 1987).”
BackgroundInfluentialEsteller, M., Levine, R., Baylin, S. B., Ellenson, L. H., & Herman, J. G. (1998) · Oncogene · doi:10.1038/sj.onc.1202178 · Cited by 493 · cited 4×
“…to lack LKB1 mutations. bTumors with LOH at LKB locus. cTumors characteristic of Peutz-Jeghers syndrome Oncogene cing of the hMLH1 by promoter hypermethylation is a frequent event in sporadic colon and endometrial carcinomas with MSI (Kane et al., 1997; Herman et al., 1998; Esteller et al., 1998b).”
BackgroundInfluentialSelf-citationTomlinson, I. P., & Houlston, R. S. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.12.1007 · Cited by 335 · cited 5×
“Interestingly, bilateral breast cancer, papillary breast carcinoma and breast papillomas are not uncommon ®ndings in PJS patients (Tomlinson and Houlston, 1997; Giardiello et al., 1987; Boardman et al., 1988; Riley and Swift, 1980).”
BackgroundInfluentialMehenni, H., Gehrig, C., Nezu, J.-I., Oku, A., Shimane, M., Rossier, C., Guex, N., Blouin, J.-L., Scott, H. S., & Antonarakis, S. E. (1998) · The American Journal of Human Genetics · doi:10.1086/302159 · Cited by 219 · cited 1×
“Supporting the LKB1 tumor suppressor role, loss of LKB1 kinase activity has been recently demonstrated in the mutant proteins derived from PJS families (Mehenni et al., 1998; Ylikorkala et al., 1999).”
Background
Cited by
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationDNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
Self-citationCpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
Esteller, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205600 · Cited by 1,233
Self-citationMetabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2022) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 770
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
Esteller, M., & Herman, J. G. (2002) · The Journal of Pathology · doi:10.1002/path.1024 · Cited by 743
Self-citationDNA methylation, methyltransferases, and cancer
Robertson, K. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204341 · Cited by 736
ABERRANT DNA METHYLATION AS A CANCER-INDUCING MECHANISM
Esteller, M. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095832 · Cited by 549
Self-citationCostello, J. F., & Plass, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.5.285 · Cited by 442
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis
Esteller, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3001 · Cited by 441
Self-citationLoss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation
Bardeesy, N., Sinha, M., Hezel, A. F., Signoretti, S., Hathaway, N. A., Sharpless, N. E., Loda, M., Carrasco, D. R., & DePinho, R. A. (2002) · Nature · doi:10.1038/nature01045 · Cited by 424
Age-associated DNA methylation in pediatric populations
Alisch, R. S., Barwick, B. G., Chopra, P., Myrick, L. K., Satten, G. A., Conneely, K. N., & Warren, S. T. (2012) · Genome Research · doi:10.1101/gr.125187.111 · Cited by 389
DNA methylation, chromatin inheritance, and cancer
Rountree, M. R., Bachman, K. E., Herman, J. G., & Baylin, S. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204339 · Cited by 384
Self-citationHighly penetrant hereditary cancer syndromes
Nagy, R., Sweet, K., & Eng, C. (2004) · Oncogene · doi:10.1038/sj.onc.1207714 · Cited by 380
Sato, N., Rosty, C., Jansen, M., Fukushima, N., Ueki, T., Yeo, C. J., Cameron, J. L., Iacobuzio-Donahue, C. A., Hruban, R. H., & Goggins, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63053-2 · Cited by 267
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches
Wong, C. C., Qian, Y., & Yu, J. (2017) · Oncogene · doi:10.1038/onc.2016.485 · Cited by 262
Rapamycin: an anti-cancer immunosuppressant?
Law, B. K. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.009 · Cited by 252
Somatic LKB1 Mutations Promote Cervical Cancer Progression
Wingo, S. N., Gallardo, T. D., Akbay, E. A., Liang, M.-C., Contreras, C. M., Boren, T., Shimamura, T., Miller, D. S., Sharpless, N. E., Bardeesy, N., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005137 · Cited by 247
Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
Gandhi, N., & Das, G. (2019) · Cells · doi:10.3390/cells8020089 · Cited by 227
cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth
Chen, Z., Li, J.-L., Lin, S., Cao, C., Gimbrone, N. T., Yang, R., Fu, D. A., Carper, M. B., Haura, E. B., Schabath, M. B., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85250 · Cited by 194
“However, LKB1 functional inactivation could result from mutations across the entire LKB1 gene, epigenetic silencing, or posttranslational inactivation (20, 22, 50), posing a great challenge for detection of LKB1 functional loss through direct genomic sequencing.”
BackgroundSIRT1 and AMPK in regulating mammalian senescence: A critical review and a working model
Wang, Y., Liang, Y., & Vanhoutte, P. M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.11.047 · Cited by 177
“colon and gastric cancers [135–137].”
Morton, J. P., Jamieson, N. B., Karim, S. A., Athineos, D., Ridgway, R. A., Nixon, C., McKay, C. J., Carter, R., Brunton, V. G., Frame, M. C., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.055 · Cited by 169
Epigenomics: Genome-Wide Study of Methylation Phenomena
(2002) · Current Issues in Molecular Biology · doi:10.21775/cimb.004.111 · Cited by 150
Kaufman, J. M., Amann, J. M., Park, K., Arasada, R. R., Li, H., Shyr, Y., & Carbone, D. P. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000173 · Cited by 87
Bonanno, L., De Paoli, A., Zulato, E., Esposito, G., Calabrese, F., Favaretto, A., Santo, A., Conte, A. D., Chilosi, M., Oniga, F., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2410 · Cited by 53
Metadata
- Authors
- Esteller, M., Avizienyte, E., Corn, P. G., Lothe, R. A., Baylin, S. B., Aaltonen, L. A., & Herman, J. G.
- Venue
- Oncogene
- Published
- 2000-01-06
- Volume
- 19
- Issue
- 1
- Pages
- 164-168
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2327039151
- Cited by
- 179
- References
- 13
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.